About us

Our Story

Dei Group International has evolved into one of the largest private sector companies in Africa with unparalleled insight into several areas that affect society, including agriculture, technology, medicine and research.

Dei Group has since birthed the following subsidiaries:

  1. Dei BioPharma Limited
  2. Dei Industries International Limited
  3. St. Angela Merici Hospital
  4. Dei Technologies International Limited
  5. Dei Minerals International Limited
  6. Dei Farms International Limited

Its founder, Dr. Matthias Magoola, has continued to follow the entrepreneurial philosophy he had developed at a young age: find a real customer need and continuously innovating to address it.

Dei Group has grown into a company that employs more than 1,200 people directly and indirectly. We expect this to grow to more than 10,000 over the next five years after we commission our bio-pharmaceutical plant in Matugga this year.

Our Mision

To deliver high quality yet affordable nutrition, health and technology products that make a difference to millions of families.

Our Vision

We are a market leader transforming millions of families through nutrition, health and technology innovations.

Our Values

  • We put end users first.
  • We strive for better.
  • We keep our word
  • We act fairly, ethically and openly in all we do
  • We are always striving towards high standards

Dei Group Ltd has over the years given birth to a growing portfolio of sub-companies across diverse sectors. Notable sub companies are;

Dei BioPharma Ltd, the flagship brand which is developing Africa’s iconic drugs and vaccines manufacturing facility in Uganda, which will create thousands of professional jobs and directly employ about 40,000 people. The iconic drugs and vaccines manufacturing facility situated at Mattuga, Wakiso District, near Kampala in Uganda, was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President). The state-of-the-art facility, valued at USD 1.1, and is gearing is gearing to produce one billion doses of mRNA vaccines guided by the most stringent global GMP including the US FDA, EU (EMA) and the World Health Organization (WHO) standards. Dei Biopharma Ltd is currently valued at USD 2.5 billion.

Medical research under Dei BioPharma, include its flagship product, the Dei Anti-Malarial drug derived from natural sources had its active ingredient isolation process performed in the United States in the latest cutting edge laboratories and was confirmed to be the most efficient anti-malarial drug ever discovered. Details can be accessed via our website.

Dei Industries International Ltd, has four factories in operation, and produces world-class grade grain flour, employing over 1,200 people. Our flag ship product is Dei Wheat, a top quality wheat flour product.

St. Angela Merici Hospital , the first of its kind, offers a new medical treatment for children with genetic illnesses including Cerebral Palsy, Sickle Cell, Autism and Down syndrome. The treatment involves a combination of Chinese originated acupuncture and Italian originated Electro homeopathy.

Dei Technologies International Limited, is transforming livelihood the world over with innovative ICT solutions. Notable products are; XMM – Cross networks and borders payments solution, Dei Places – Social media platform to share places and experiences and promoting the African tourism industry.

Our Partners

Mutta tulokset ovat erityisen epämiellyttäviä kotimaisten ystävien kanssa, jotka antavat sisäisiä tutkimuksia, joiden mukaan noin puolet venäläisistä naisista (49%) ei koskaan koe orgasmia sukupuolesta miehensä kanssa. Ajattele ajattelua: Puolet Pietarin, Moskovan, Irkutskin viagra Finland Nizhny Novgorodin naisista, joissa yksi tutkimuksesta pidettiin vuonna 2014, ei koskaan kärsi seksistä! Hän kärsii näistä kiusallisista liikkeistä miehen hyväksi.

Dei Group International